Aaron Davis
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Mr. Aaron I.
Davis is a Chief Executive Officer at Boxer Capital Management LLC, an Executive Chairman at CiVi Biopharma Holdings, Inc., a Chief Executive Officer at Boxer Capital Management LLC /Private Equity/ and a Chief Executive Officer at MVA Investors LLC.
He is on the Board of Directors at CiVi Biopharma, Inc., Flare Therapeutics, Inc. and Tango Therapeutics Sub, Inc.
Mr. Davis was previously employed as an Independent Director by Rain Oncology, Inc., a Chairman & Chief Executive Officer by BCTG Acquisition Corp., an Independent Director by Tango Therapeutics, Inc., an Independent Director by iTeos Therapeutics, Inc., an Independent Director by Mirati Therapeutics, Inc., an Independent Director by Odonate, Inc., a Vice President by Tavistock Life Sciences Co., a Portfolio Manager by Tavistock Group, Inc. (United States), and a Principal by UBS Securities LLC.
He also served on the board at Sojournix, Inc. and Kalypsys, Inc.
He received his undergraduate degree from Emory University and a graduate degree from The Trustees of Columbia University in The City of New York.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/12/2024 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
CiVi Biopharma, Inc.
CiVi Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which manufactures novel therapies against cardiovascular and metabolic diseases | Directeur/Membre du Conseil | - |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Directeur/Membre du Conseil | - |
MVA Investors LLC
MVA Investors LLC Financial ConglomeratesFinance Provides investment services | Directeur Général | - |
CiVi Biopharma Holdings, Inc.
CiVi Biopharma Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage research and development biotechnology company | Président | 01/01/2016 |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2024 |
| RAIN ONCOLOGY INC. | Directeur/Membre du Conseil | 25/01/2024 |
| MIRATI THERAPEUTICS | Directeur/Membre du Conseil | 23/01/2024 |
| TANGO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 29/08/2023 |
| ░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 18 |
|---|---|
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University
Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Tavistock Life Sciences Co.
Tavistock Life Sciences Co. Investment ManagersFinance Tavistock Life Sciences invests in both public and private companies located in the United States. The firm focuses on life science companies with exceptional technology profiles. It provides financing for early stage capital requirements. | Finance |
MVA Investors LLC
MVA Investors LLC Financial ConglomeratesFinance Provides investment services | Finance |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
CiVi Biopharma, Inc.
CiVi Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which manufactures novel therapies against cardiovascular and metabolic diseases | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients | Health Technology |
CiVi Biopharma Holdings, Inc.
CiVi Biopharma Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage research and development biotechnology company | Commercial Services |
Tavistock Group, Inc. (United States)
Tavistock Group, Inc. (United States) Financial ConglomeratesFinance Provides investment services | Finance |
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
BCTG Acquisition Corp.
BCTG Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national